These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21266)

  • 41. Comparison of central effects of noradrenaline and dopamine injected into the lateral brain ventricle in rats.
    Zebrowska-Lupina I; Malec D; Kleinrok Z
    Acta Physiol Pol; 1975; 26(3):261-74. PubMed ID: 1242288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amphetamine-induced locomotor activity and stereotypy after kainic acid lesions of the striatum.
    Mason ST; Sanberg PR; Fibiger HC
    Life Sci; 1978 Feb; 22(6):451-9. PubMed ID: 24160
    [No Abstract]   [Full Text] [Related]  

  • 43. Influence of adenosine receptor agonists and antagonists on amphetamine-induced stereotypy in rats.
    Poleszak E; Malec D
    Pol J Pharmacol; 2000; 52(6):423-9. PubMed ID: 11334236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of fasting on the stereotyped behaviour induced by amphetamine and by apomorphine in the albino rat.
    Fuenmayor LD; Diaz S
    Eur J Pharmacol; 1984 Mar; 99(2-3):153-8. PubMed ID: 6539708
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biochemistry and behavior: some central actions of amphetamine and antipsychotic drugs.
    Groves PM; Rebec GV
    Annu Rev Psychol; 1976; 27():91-127. PubMed ID: 773267
    [No Abstract]   [Full Text] [Related]  

  • 46. [Antipsychotic drug modification of motor hyperactivity and stereotyped behavior induced by amphetamine in rats with lesions in the nigrostriatal and mesolymbic dopaminergic systems].
    Sánchez-Blázquez P; Fernández-Tomé MP; Fuentes JA; del Río J
    Arch Farmacol Toxicol; 1978 Apr; 4(1):66-8. PubMed ID: 29574
    [No Abstract]   [Full Text] [Related]  

  • 47. Enkephalin prevents CCK-induced enhancement of amphetamine-induced locomotor stereotypy.
    Mueller K; Whiteside DA
    Brain Res; 1990 Apr; 513(1):119-24. PubMed ID: 2350675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacology of trazodone.
    Silverstrini B; Lisciani R
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):749-54. PubMed ID: 4201971
    [No Abstract]   [Full Text] [Related]  

  • 49. An investigation on the behavioral and hypothermic effects of yohimbine: interaction with drugs affecting central and peripheral monoamines.
    Papeschi R
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):61-80. PubMed ID: 4276928
    [No Abstract]   [Full Text] [Related]  

  • 50. [Model of the defense reaction in rats to study the antifenamine effect of neuroleptics for demonstrating their specific action].
    Baturin VA; Iuntsev SV
    Farmakol Toksikol; 1984; 47(5):110-3. PubMed ID: 6149952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amphetamine stereotypy, the basal ganglia, and the "selection problem".
    Wolgin DL
    Behav Brain Res; 2012 Jun; 231(2):297-308. PubMed ID: 22101067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methodone interaction with apomorphine- and amphetamine-induced turning.
    Stratten WP
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):675-8. PubMed ID: 1237160
    [No Abstract]   [Full Text] [Related]  

  • 53. Dopaminergic nature of amphetamine-induced pecking in pigeons.
    Cheng HC; Bhatnagar RK; Long JP
    Eur J Pharmacol; 1975; 33(2):319-24. PubMed ID: 1237409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of dopamine-like compounds on stereotypy and locomotor activity in atropinized rats.
    Grabowska M
    Arch Immunol Ther Exp (Warsz); 1975; 23(6):753-61. PubMed ID: 1241267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new animal model for schizophrenia: interactions with adrenergic mechanisms.
    Borison RL; Diamond BI
    Biol Psychiatry; 1978 Apr; 13(2):217-25. PubMed ID: 208665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evolving behavior in the clinical and experimental amphetamine (model) psychosis.
    Ellinwood EH; Sudilovsky A; Nelson LM
    Am J Psychiatry; 1973 Oct; 130(10):1088-93. PubMed ID: 4353974
    [No Abstract]   [Full Text] [Related]  

  • 57. Opposite modulation of apomorphine- or amphetamine-induced stereotypy by antagonists of CCK receptors.
    Tieppo CA; Ferreira FS; Sassatani AS; Felicio LF; Nasello AG
    Eur J Pharmacol; 2000 Jan; 387(2):189-96. PubMed ID: 10650159
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of the calcium channel blockers on rotation induced by apomorphine and amphetamine in rats lesioned with 6-hydroxydopamine].
    Tabernero C; Pardo B; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54(2):49-53. PubMed ID: 1907126
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sensitization of amphetamine-induced stereotyped behaviors during the acute response: role of D1 and D2 dopamine receptors.
    Kuczenski R; Segal DS
    Brain Res; 1999 Mar; 822(1-2):164-74. PubMed ID: 10082894
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MJ 9022: correlation between neuroleptic potential and stereotypy.
    Sathananthan GL; Sanghvi I; Phillips N; Gershon S
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):701-5. PubMed ID: 1208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.